Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-α2b and histamine dihydrochloride versus dacarbazine in patients with stage IV melanoma-Reference-Cited by-同舟云学术

Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-α2b and histamine dihydrochloride versus dacarbazine in patients with stage IV melanoma

Published:2007-10 Issue:10 Volume:18 Page:1691-1697
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Middleton M.,Hauschild A.,Thomson D.,Anderson R.,Burdette-Radoux S.,Gehlsen K.,Hellstrand K.,Naredi P.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/18/10/1691/309558/mdm331.pdf

Reference22 articles.

1. Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years?;Eggermont;Eur J Cancer,2004

2. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma;Middleton;J Clin Oncol,2000

3. Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study;Avril;J Clin Oncol,2004

4. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993;Atkins;J Clin Oncol,1999

5. Studies of interferons in the therapy of melanoma;Kirkwood;Semin Oncol,1991

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Results of Treatment of Patients with Stage IV Malignant Melanoma in the Sverdlovsk Region;Ural Medical Journal;2024-09-03

2. Mechanisms of resistance to immune checkpoint inhibitors in melanoma: What we have to overcome?;Cancer Treatment Reviews;2023-02

3. Direct and indirect effects of IFN-α2b in malignancy treatment: not only an archer but also an arrow;Biomarker Research;2022-09-14

4. Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside;Frontiers in Endocrinology;2021-11-05

5. Histamine in cancer immunology and immunotherapy. Current status and new perspectives;Pharmacology Research & Perspectives;2021-10